| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alcohol consumption and lung cancer risk in never smokers: a meta-analysis
|
Bagnardi, V.
|
|
|
22 |
12 |
p. 2631-2639
|
artikel
|
| 2 |
An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival
|
Korse, C.M.
|
|
|
22 |
12 |
p. 2625-2630
|
artikel
|
| 3 |
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer
|
Fornier, M.N.
|
|
|
22 |
12 |
p. 2575-2581
|
artikel
|
| 4 |
Bendamustine and rituximab is effective and cost-effective in older cases with aggressive lymphomas?
|
Paydas, S.
|
|
|
22 |
12 |
p. 2694-2695
|
artikel
|
| 5 |
Better value cancer care for the 21st century
|
Gray, M.
|
|
|
22 |
12 |
p. 2541-2545
|
artikel
|
| 6 |
Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays
|
Brogi, E.
|
|
|
22 |
12 |
p. 2597-2603
|
artikel
|
| 7 |
Consistency of breast density measured from the same women using different MR scanners
|
Chen, J.-H.
|
|
|
22 |
12 |
p. 2693-2694
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
22 |
12 |
p. ii-iii
|
artikel
|
| 9 |
Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients
|
Cassidy, J.
|
|
|
22 |
12 |
p. 2604-2609
|
artikel
|
| 10 |
High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH)
|
Kenz, S.
|
|
|
22 |
12 |
p. 2696
|
artikel
|
| 11 |
Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer
|
Wu, Y.
|
|
|
22 |
12 |
p. 2582-2590
|
artikel
|
| 12 |
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice
|
Sequist, L.V.
|
|
|
22 |
12 |
p. 2616-2624
|
artikel
|
| 13 |
Late effects in survivors of teenage and young adult cancer: does age matter?
|
Woodward, E.
|
|
|
22 |
12 |
p. 2561-2568
|
artikel
|
| 14 |
Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
|
Hadji, P.
|
|
|
22 |
12 |
p. 2546-2555
|
artikel
|
| 15 |
Metabolic syndrome and the risk of breast cancer in postmenopausal women
|
Rosato, V.
|
|
|
22 |
12 |
p. 2687-2692
|
artikel
|
| 16 |
Metformin in prostate cancer: two for the price of one
|
Clements, A.
|
|
|
22 |
12 |
p. 2556-2560
|
artikel
|
| 17 |
Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004–05 study
|
Martín, M.
|
|
|
22 |
12 |
p. 2591-2596
|
artikel
|
| 18 |
Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activity
|
Bellmunt, J.
|
|
|
22 |
12 |
p. 2646-2653
|
artikel
|
| 19 |
Pilot trial of sunitinib therapy in patients with von Hippel–Lindau disease
|
Jonasch, E.
|
|
|
22 |
12 |
p. 2661-2666
|
artikel
|
| 20 |
Potential role of phytoestrogens in the pathophysiology of fibromatosis
|
Thanopoulou, E.
|
|
|
22 |
12 |
p. 2697-2698
|
artikel
|
| 21 |
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
|
Oechsle, K.
|
|
|
22 |
12 |
p. 2654-2660
|
artikel
|
| 22 |
Professional failure: how do oncologists feel it?
|
Berardi, R.
|
|
|
22 |
12 |
p. 2696-2697
|
artikel
|
| 23 |
Reduced incidence of second solid tumors in survivors of childhood Hodgkin's lymphoma treated without radiation therapy
|
Barbaro, P.M.
|
|
|
22 |
12 |
p. 2569-2574
|
artikel
|
| 24 |
Second cancers following Hodgkin’s lymphoma: radiation therapy once more
|
Meadows, A.T.
|
|
|
22 |
12 |
p. 2539-2540
|
artikel
|
| 25 |
Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer
|
Iqbal, S.
|
|
|
22 |
12 |
p. 2610-2615
|
artikel
|
| 26 |
Table of Contents
|
|
|
|
22 |
12 |
p. iv-v
|
artikel
|
| 27 |
The end of the beginning of personalized medicine
|
Natoli, G.
|
|
|
22 |
12 |
p. 2695
|
artikel
|
| 28 |
The role of relatives in decisions concerning life-prolonging treatment in patients with end-stage malignant disorders: informants, advocates or surrogate decision-makers?
|
Hauke, D.
|
|
|
22 |
12 |
p. 2667-2674
|
artikel
|
| 29 |
Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients
|
He, X.-X.
|
|
|
22 |
12 |
p. 2640-2645
|
artikel
|
| 30 |
Worldwide burden of cervical cancer in 2008
|
Arbyn, M.
|
|
|
22 |
12 |
p. 2675-2686
|
artikel
|
Tijdschrift beschrijving